(Q35163098)

6 August 2017

1 reference

title

The utility of marginal donors in liver transplantation (English)

1 reference

6 August 2017

main subject

liver transplantation

1 reference

2

Koichi Tanaka

1 reference

6 August 2017

Ronald W Busuttil

1

1 reference

6 August 2017

publication date

1 July 2003

1 reference

6 August 2017

published in

Liver Transplantation

1 reference

6 August 2017

volume

9

1 reference

6 August 2017

issue

7

1 reference

6 August 2017

page(s)

651-663

1 reference

Improvement of rat liver function by energy repletion after the preservation period: implications for hepatic graft management

6 August 2017

cites work

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Liver transplantation: expanding the donor pool

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

L-Selectin and chemokine response after liver ischemia and reperfusion

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Donor fatty (steatotic) liver allografts in orthotopic liver transplantation: a revisit

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Influence of marginal donors on liver preservation injury

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Is the use of marginal liver grafts justified?

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Protection by Carolina rinse solution, acidotic pH, and glycine against lethal reperfusion injury to sinusoidal endothelial cells of rat livers stored for transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Hepatic ischemia-reperfusion injury

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Recurrent and new hepatitis C virus infection after liver transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Implication of advanced donor age on the outcome of liver transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Expanded liver donor age over 60 years for hepatic transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Preservation-induced liver injury. Clinical aspects, mechanisms and therapeutic approaches

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Impact of marginal quality donors on the outcome of liver transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Hepatitis C infection in liver transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

The use of the endothelin receptor antagonist, tezosentan, before or after renal ischemia protects renal function

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Beneficial effects of pentoxifylline pretreatment in non-heart-beating donors in rats

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Donor-recipient sharing of HLA class II alleles predicts earlier recurrence and accelerated progression of hepatitis C following liver transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Long-term outcome of patients transplanted with livers from hepatitis C-positive donors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

P-selectin and chemokine response after liver ischemia and reperfusion

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Evaluation of rat liver apoptotic and necrotic cell death after cold storage using UW, HTK, and Celsior

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

l-ARGININE REDUCES LIVER AND BILIARY TRACT DAMAGE AFTER LIVER TRANSPLANTATION FROM NON-HEART-BEATING DONOR PIGS1

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Why is fatty liver unsuitable for transplantation? Deterioration of mitochondrial ATP synthesis and sinusoidal structure during cold preservation of a liver with steatosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

The impact of a positive crossmatch upon outcome after liver transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Outcome of patients with renal insufficiency undergoing liver or liver-kidney transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

A novel iron chelator in combination with a P-selectin antagonist prevents ischemia/reperfusion injury in a rat liver model

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Experience with liver and kidney allografts from non-heart-beating donors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

The predictive value of donor liver biopsies for the development of primary nonfunction after orthotopic liver transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Use of livers with microvesicular fat safely expands the donor pool

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Heme oxygenase-1 gene transfer inhibits inducible nitric oxide synthase expression and protects genetically fat Zucker rat livers from ischemia-reperfusion injury

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

De novo hepatitis B after liver transplantation from hepatitis B core antibody—Positive donors in an area with high prevalence of anti-HBc positivity in the donor population

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Role of platelets in hepatic allograft preservation injury in the rat

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Controlled non-heart-beating donor liver transplantation: a successful single center experience, with topic update

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Donor brain death reduces survival after transplantation in rat livers preserved for 20 hr.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Contribution of true cold and rewarming ischemia times to factors determining outcome after orthotopic liver transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Liver transplantation after organ preservation with normothermic extracorporeal perfusion.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

The use of older donor livers for hepatic transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Improved survival through the reduction of ischemia-reperfusion injury after rat intestinal transplantation using selective P-selectin blockade with P-selectin glycoprotein ligand-Ig

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Morphologic alteration of hepatocytes and sinusoidal endothelial cells in rat fatty liver during cold preservation and the protective effect of hepatocyte growth factor

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Use of octogenarian livers safely expands the donor pool

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

P-selectin contributes to the initial recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Heme oxygenase-1 system in organ transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Transplant tumor registry: donor related malignancies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Sinusoidal endothelial cell injury during hepatic preservation and reperfusion

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

P-selectin glycoprotein ligand-1 (rPSGL-Ig)-mediated blockade of CD62 selectin molecules protects rat steatotic liver grafts from ischemia/reperfusion injury

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

A prospective study on the reliability and cost effectiveness of preoperative ultrasound screening of the "marginal" liver donor.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Use of fatty donor liver is associated with diminished early patient and graft survival.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Risk factors for primary dysfunction after liver transplantation--a multivariate analysis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Treatment of experimental ischemia/reperfusion injury with S-adenyosylmethionine: evidence that donor pretreatment complements other regimens

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Pilot study: Carolina Rinse Solution improves graft function after orthotopic liver transplantation in humans

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Safe use of livers from donors with positive hepatitis B core antibody

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Role of gender and race mismatch and graft failure in patients undergoing liver transplantation

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Reduction of hepatic acute phase response after partial hepatectomy in elderly patients

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Policies in Europe on "marginal quality" donor livers

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Dual role of Kupffer cell activation and endothelial cell damage in reperfusion injury to livers stored for transplantation surgery

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Prevention of de novo hepatitis B infection in recipients of hepatic allografts from anti-HBc positive donors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Transplant tumor registry: donors with central nervous system tumors1.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

The outcome of liver grafts procured from hepatitis C-positive donors

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Glutathione, lactobionate, and histidine: cryptic inhibitors of matrix metalloproteinases contained in University of Wisconsin and histidine/tryptophan/ketoglutarate liver preservation solutions.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

The impact of donor age on liver transplantation: influence of donor age on early liver function and on subsequent patient and graft survival.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Primary nonfunction of hepatic allografts with preexisting fatty infiltration

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1053/JLTS.2003.50105

Identifiers

DOI

10.1053/JLTS.2003.50105

1 reference

6 August 2017

1 reference